Skip to main content
Premium Trial:

Request an Annual Quote

Helix Receives $125K Milestone Payment from Lumera

NEW YORK, Feb. 13 (GenomeWeb News) - Helix BioPharma said last week that it has received a $125,000 milestone payment from Lumera under the terms of a licensing agreement for Helix's heterodimer protein technology.


Lumera is currently developing a high-throughput, label-free protein detection platform, which incorporates the Helix technology, through a collaboration with the Institute for Systems Biology.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more